Home / Resource Library / Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study

Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study

Study investigated the use of bispecifics as consolidation therapy prior to allogeneic stem cell transplant.